Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Spinella JF"'
Autor:
Grenier JMP; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France.; UMR 7268, Aix-Marseille Université, EFS, CNRS, GENGLOBE, Marseille, France., Testut C; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Bal M; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France.; Département de la Recherche Clinique et de l'Innovation, Institut Paoli-Calmettes, Marseille, France., Bardin F; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., De Grandis M; Aix-Marseille University, CNRS, EFS, ADES, Biologie des Groupes Sanguins, Marseille, France.; UMR 7268, Aix-Marseille Université, EFS, CNRS, GENGLOBE, Marseille, France., Gelsi-Boyer V; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Vernerey J; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Delahaye M; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Granjeaud S; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Zemmour C; Département de la Recherche Clinique et de l'Innovation, Institut Paoli-Calmettes, Marseille, France., Spinella JF; Laboratory of Molecular Genetics of Stem Cells, Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada., Chavakis T; Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Mancini SJC; UMR 1236, University of Rennes, INSERM, Etablissement Français du Sang Bretagne, Rennes, France., Boher JM; Département de la Recherche Clinique et de l'Innovation, Institut Paoli-Calmettes, Marseille, France., Hébert J; Division of Hematology-Oncology, Department of Medicine, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal, QC, Canada., Sauvageau G; Laboratory of Molecular Genetics of Stem Cells, Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada., Vey N; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Schwaller J; Department of Biomedicine, University Children's Hospital, University of Basel, Basel, Switzerland., Hospital MA; Département d'Hématologie, Institut Paoli-Calmettes, Marseille, France., Fauriat C; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Aurrand-Lions M; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France.
Publikováno v:
Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4662-4678.
Autor:
Bordeleau ME; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada. Electronic address: marie.eve.bordeleau@umontreal.ca., Audemard É; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Métois A; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Theret L; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Lisi V; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC H3T 1C5, Canada., Farah A; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC H3T 1C5, Canada., Spinella JF; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Chagraoui J; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Moujaber O; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Aubert L; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Khakipoor B; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC H3T 1C5, Canada., Mallinger L; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Boivin I; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Mayotte N; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Hajmirza A; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Bonneil É; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Béliveau F; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC H1T 2M4, Canada., Pfammatter S; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Feghaly A; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Boucher G; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Gendron P; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada., Thibault P; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Department of Chemistry, Faculty of Arts and Science, Université de Montréal, Montréal, QC H3T 1J4, Canada., Barabé F; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Centre de Recherche du Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC G1V 4G2, Canada., Lemieux S; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada. Electronic address: s.lemieux@umontreal.ca., Richard-Carpentier G; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada; Department of Medicine, Division of Medical Oncology and Hematology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada. Electronic address: guillaume.richard-carpentier@uhn.ca., Hébert J; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC H1T 2M4, Canada; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, QC H1T 2M4, Canada. Electronic address: josee.hebert@umontreal.ca., Lavallée VP; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC H3T 1C5, Canada; Department of Pediatrics, Faculty of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada; Hematology and Oncology Division, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC H3T 1C5, Canada. Electronic address: vincent-philippe.lavallee@umontreal.ca., Roux PP; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada. Electronic address: philippe.roux@umontreal.ca., Sauvageau G; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC H1T 2M4, Canada; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, QC H1T 2M4, Canada. Electronic address: guy.sauvageau@umontreal.ca.
Publikováno v:
Cell reports [Cell Rep] 2024 Jun 25; Vol. 43 (6), pp. 114260. Date of Electronic Publication: 2024 Jun 04.
Autor:
Moison C; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Gracias D; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Schmitt J; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Girard S; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Spinella JF; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Fortier S; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Boivin I; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Mendoza-Sanchez R; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Thavonekham B; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., MacRae T; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Mayotte N; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Bonneil E; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Wittman M; Research and Development, Bristol Myers Squibb Company, Cambridge, MA, USA., Carmichael J; Research and Development, Bristol Myers Squibb Company, Cambridge, MA, USA., Ruel R; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Thibault P; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.; Department of Chemistry, Université de Montréal, Montréal, Canada., Hébert J; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.; Division of Hematology-Oncology and Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, Canada.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada., Marinier A; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.; Department of Chemistry, Université de Montréal, Montréal, Canada., Sauvageau G; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.; Division of Hematology-Oncology and Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, Canada.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.
Publikováno v:
Science advances [Sci Adv] 2024 Mar 22; Vol. 10 (12), pp. eadl4018. Date of Electronic Publication: 2024 Mar 22.
Autor:
Spinella JF; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; The Leucegene Project, Université de Montréal, Montréal, QC, Canada., Chagraoui J; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; The Leucegene Project, Université de Montréal, Montréal, QC, Canada., Moison C; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; The Leucegene Project, Université de Montréal, Montréal, QC, Canada., Lavallée VP; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; The Leucegene Project, Université de Montréal, Montréal, QC, Canada.; Sainte-Justine Research Center, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.; Department of Pediatrics, Université de Montréal, Montréal, QC, Canada., Boivin I; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; The Leucegene Project, Université de Montréal, Montréal, QC, Canada., Gracias D; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; The Leucegene Project, Université de Montréal, Montréal, QC, Canada., Lavallée S; The Leucegene Project, Université de Montréal, Montréal, QC, Canada.; Leukemia Cell Bank of Quebec, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada., Carpentier GR; The Leucegene Project, Université de Montréal, Montréal, QC, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medicine, Division of Medical Oncology and Hematology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Beliveau F; The Leucegene Project, Université de Montréal, Montréal, QC, Canada.; Leukemia Cell Bank of Quebec, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada., Hébert J; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada. josee.hebert@umontreal.ca.; The Leucegene Project, Université de Montréal, Montréal, QC, Canada. josee.hebert@umontreal.ca.; Leukemia Cell Bank of Quebec, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada. josee.hebert@umontreal.ca.; Division of Hematology, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada. josee.hebert@umontreal.ca.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada. josee.hebert@umontreal.ca., Sauvageau G; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada. guy.sauvageau@umontreal.ca.; The Leucegene Project, Université de Montréal, Montréal, QC, Canada. guy.sauvageau@umontreal.ca.; Leukemia Cell Bank of Quebec, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada. guy.sauvageau@umontreal.ca.; Division of Hematology, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada. guy.sauvageau@umontreal.ca.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada. guy.sauvageau@umontreal.ca.
Publikováno v:
Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 530-537. Date of Electronic Publication: 2023 Dec 15.
Autor:
Moison C; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Spinella JF; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Chagraoui J; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Lavallée VP; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Division of Pediatric Hematology-Oncology, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.; Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.; Department of Pediatrics, Faculty of Medicine, and., Lehnertz B; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Thiollier C; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Boivin I; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Mayotte N; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., MacRae T; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Marinier A; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Department of Chemistry, Université de Montréal, Montréal, QC, Canada., Hébert J; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada.; Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital Research Center, Montréal, QC, Canada; and.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Sauvageau G; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada.; Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital Research Center, Montréal, QC, Canada; and.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
Publikováno v:
Blood advances [Blood Adv] 2022 Aug 23; Vol. 6 (16), pp. 4793-4806.
Autor:
Supper E; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK., Rudat S; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK., Iyer V; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK., Droop A; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK., Wong K; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK., Spinella JF; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, 2950 Chemin de Polytechnique Pavillon, Marcelle-Coutu, Montréal, QC, Canada., Thomas P; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK., Sauvageau G; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, 2950 Chemin de Polytechnique Pavillon, Marcelle-Coutu, Montréal, QC, Canada., Adams DJ; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK., Wong CC; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK. cw6@sanger.ac.uk.; Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. cw6@sanger.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Apr 30; Vol. 12 (1), pp. 2482. Date of Electronic Publication: 2021 Apr 30.
Autor:
Chagraoui J; Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., Girard S; Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., Spinella JF; Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., Simon L; Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., Bonneil E; Departments of Biochemistry and Chemistry, Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada., Mayotte N; Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., MacRae T; Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., Coulombe-Huntington J; Department of Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., Bertomeu T; Department of Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., Moison C; Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., Tomellini E; Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., Thibault P; Departments of Biochemistry and Chemistry, Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada., Tyers M; Department of Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada., Marinier A; Faculty of Arts and Science, Université de Montréal, Montreal, QC, Canada., Sauvageau G; Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada. Electronic address: guy.sauvageau@umontreal.ca.
Publikováno v:
Cell stem cell [Cell Stem Cell] 2021 Jan 07; Vol. 28 (1), pp. 48-62.e6.
Autor:
Simon L; The Leucegene Project at Institute for Research in Immunology and Cancer and., Spinella JF; The Leucegene Project at Institute for Research in Immunology and Cancer and., Yao CY; The Leucegene Project at Institute for Research in Immunology and Cancer and., Lavallée VP; The Leucegene Project at Institute for Research in Immunology and Cancer and., Boivin I; The Leucegene Project at Institute for Research in Immunology and Cancer and., Boucher G; The Leucegene Project at Institute for Research in Immunology and Cancer and., Audemard E; The Leucegene Project at Institute for Research in Immunology and Cancer and., Bordeleau ME; The Leucegene Project at Institute for Research in Immunology and Cancer and., Lemieux S; The Leucegene Project at Institute for Research in Immunology and Cancer and.; Department of Biochemistry, Université de Montréal, Montréal, QC, Canada., Hébert J; The Leucegene Project at Institute for Research in Immunology and Cancer and.; Division of Hematology-Oncology and.; Leukemia Cell Bank of Quebec, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada; and.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Sauvageau G; The Leucegene Project at Institute for Research in Immunology and Cancer and.; Division of Hematology-Oncology and.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
Publikováno v:
Blood [Blood] 2020 May 21; Vol. 135 (21), pp. 1882-1886.
Autor:
Bisaillon R; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Moison C; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Thiollier C; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Krosl J; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Bordeleau ME; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Lehnertz B; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Lavallée VP; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Division of Hematology, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada., MacRae T; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Mayotte N; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Labelle C; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Department of Computer Science and Operations Research, Université de Montréal, Montréal, QC, Canada., Boucher G; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Spinella JF; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Boivin I; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., D'Angelo G; Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada., Lavallée S; Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada., Marinier A; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Department of Chemistry, Université de Montréal, Montréal, QC, Canada., Lemieux S; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Department of Computer Science and Operations Research, Université de Montréal, Montréal, QC, Canada., Hébert J; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Division of Hematology, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada.; Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Sauvageau G; The Leucegene Project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada. guy.sauvageau@umontreal.ca.; Division of Hematology, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada. guy.sauvageau@umontreal.ca.; Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada. guy.sauvageau@umontreal.ca.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada. guy.sauvageau@umontreal.ca.
Publikováno v:
Leukemia [Leukemia] 2020 Jan; Vol. 34 (1), pp. 63-74. Date of Electronic Publication: 2019 Jul 12.
Autor:
Cardin S; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada., Bilodeau M; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada., Roussy M; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada.; Department of Biomedical Sciences.; Faculty of Medicine., Aubert L; Cell Signaling and Proteomics Research Unit, and.; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Milan T; Laboratory for High-Throughput Biology, Institute for Research in Immunology and Cancer, Montréal, QC, Canada., Jouan L; Integrated Centre for Pediatric Clinical Genomics, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Rouette A; Integrated Centre for Pediatric Clinical Genomics, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Laramée L; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada., Gendron P; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Bioinformatics Platform, Université de Montréal, Montréal, QC, Canada., Duchaine J; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Decaluwe H; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada.; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Spinella JF; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada.; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Mourad S; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada., Couture F; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada., Sinnett D; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada.; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada., Haddad É; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada.; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Department of Microbiology, Infectiology and Immunology, CHU Sainte-Justine, Montréal, QC, Canada., Landry JR; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada.; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Streamline Genomics, Montréal, QC, Canada., Ma J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN., Humphries RK; British Columbia Cancer Agency, Vancouver, BC, Canada., Roux PP; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Laboratory for High-Throughput Biology, Institute for Research in Immunology and Cancer, Montréal, QC, Canada.; Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Hébert J; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Division of Hematology, and.; Québec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada; and., Gruber TA; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Wilhelm BT; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Laboratory for High-Throughput Biology, Institute for Research in Immunology and Cancer, Montréal, QC, Canada., Cellot S; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montréal, QC, Canada.; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Québec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada; and.
Publikováno v:
Blood advances [Blood Adv] 2019 Nov 12; Vol. 3 (21), pp. 3307-3321.